| Name | |
|---|---|
| Active Substance | |
| Marketing Authorisation Date | .. |
| MA Period of Validity | .. |
| MA Revocation Date | .. |
| Type of prescription | Medicinal product subject to restricted medical prescription |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o riziku od tromboze, uključujući cerebralni infarkt, nakon naglog prekida liječenja anagrelidom | 11.03.2022 | Stada d.o.o., Pliva Hrvatska d.o.o., Alpha-Medical d.o.o., Zentiva k.s., AOP Orphan Pharmaceuticals GmbH |
